SUPPLEMENT
Q1 2024 — Income statement trends
Q1 2024PDF · 2 pages144 KB
CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q122 Q222 Q322 Q422 Q123 Q223 Q323 Q423 Q124 Revenues: Clearing and transaction fees 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 Market data and information services 151.7 151.7 154.3 153.2 165.8 163.1 167.6 167.2 175.4 Other Revenue 56.8 60.9 74.9 73.2 75.6 78.8 84.7 87.6 103.6 Total revenues 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 Expenses: Compensation and benefits 185.2 185.3 189.6 193.0 204.5 205.7 205.5 212.9 206.0 Technology 45.9 45.9 46.8 50.0 51.3 53.3 55.6 58.5 59.4 Professional fees and outside services 31.8 32.0 35.1 38.5 38.3 37.8 32.2 36.1 33.1 Amortization of purchased intangibles 58.4 57.1 55.5 56.7 56.8 57.0 57.2 55.6 55.2 Depreciation and amortization 33.5 33.0 34.5 33.9 31.9 32.3 31.1 30.7 30.1 Licensing and other fee agreements 80.9 83.1 83.6 72.4 84.7 78.2 79.5 80.4 87.9 Other expense 51.8 51.1 43.9 95.0 60.4 57.3 56.5 101.9 56.6 Operating expenses 487.5 487.5 489.0 539.5 527.9 521.6 517.6 576.1 528.3 Operating Income 859.1 749.7 738.8 668.3 913.7 838.6 820.2 863.2 959.6 Operating Margin 64% 61% 60% 55% 63% 62% 61% 60% 64% Non-operating Income and Expense Investment income 73.1 286.9 686.2 1,152.2 1,357.7 1,568.2 1,272.5 1,076.9 1,071.3 Interest and other borrowing costs (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) (39.7) (39.9) Equity in net gains (losses) of unconsolidated subsidiaries 73.3 87.3 76.5 64.0 78.2 75.1 76.8 66.8 87.2 Other non-operating income (expense) (46.7) (217.3) (581.1) (1,017.3) (1,152.8) (1,425.3) (1,155.6) (961.2) (964.8) Non-operating income (expense) 57.2 117.0 141.2 159.0 243.2 177.8 154.1 142.8 153.8 Income before income taxes 916.3 866.7 880.0 827.3 1,156.9 1,016.4 974.3 1,006.0 1,113.4 Income taxes 205.3 204.2 200.4 189.4 273.1 238.8 224.1 191.4 258.2 Net income 711.0 662.5 679.6 637.9 883.8 777.6 750.2 814.6 855.2 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 711.0 662.5 679.6 637.9 883.8 777.6 750.2 814.6 855.2 Net Income Attributable to Common Shareholders of CME Group 702.0 654.1 671.1 629.9 872.7 767.8 740.8 804.3 844.4 Effective Tax Rate 22.4% 23.6% 22.8% 22.8% 23.6% 23.5% 23.0% 19.0% 23.2% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.96 1.82 1.87 1.76 2.43 2.14 2.06 2.24 2.35 Diluted EPS 1.95 1.82 1.87 1.75 2.43 2.14 2.06 2.24 2.35 Weighted average number of common stock shares: Basic Shares 358,609 358,641 358,715 358,885 358,933 358,940 359,020 359,197 359,258 Diluted Shares 359,180 359,205 359,288 359,190 359,313 359,429 359,619 359,693 359,833 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q122 Q222 Q322 Q422 Q123 Q223 Q323 Q423 Q124 Revenues: Clearing and transaction fees 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 Market data and information services 151.7 151.7 154.3 153.2 165.8 163.1 167.6 167.2 175.4 Other Revenue 56.8 60.9 74.9 73.2 75.6 78.8 84.7 87.6 103.6 Total revenues 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 Expenses: Compensation and benefits 182.8 189.5 189.1 184.6 192.8 194.4 193.5 204.4 196.1 Technology 45.8 45.9 46.8 50.0 51.3 53.3 55.6 58.5 59.4 Professional fees and outside services 30.3 31.4 35.1 38.5 38.3 37.8 32.2 36.1 33.1 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 33.5 32.9 33.8 33.9 31.9 31.8 31.1 29.8 29.3 Licensing and other fee agreements 80.9 83.1 81.9 72.4 84.7 78.2 79.5 80.4 87.9 Other expense 51.7 59.6 54.4 84.5 59.7 56.2 56.5 80.3 56.5 Operating expenses 425.0 442.4 441.1 463.9 458.7 451.7 448.4 489.5 462.3 Operating Income 921.6 794.8 786.7 743.9 982.9 908.5 889.4 949.8 1,025.6 Operating Margin 68% 64% 64% 62% 68% 67% 66% 66% 69% Non-operating Income and Expense Investment income 74.7 299.5 688.5 1,147.1 1,277.5 1,564.0 1,276.6 1,068.5 1,061.7 Interest and other borrowing costs (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) (39.7) (39.9) Equity in net gains (losses) of unconsolidated subsidiaries 84.7 98.2 89.6 76.2 91.5 88.6 90.4 85.1 100.7 Other non-operating income (expense) (43.4) (218.5) (585.7) (1,023.3) (1,160.6) (1,429.9) (1,157.1) (958.8) (964.8) Non-operating income (expense) 73.5 139.3 152.0 160.1 168.5 182.5 170.3 155.1 157.7 Income before income taxes 995.1 934.1 938.7 904.0 1,151.4 1,091.0 1,059.7 1,104.9 1,183.3 Income taxes 228.9 217.6 219.6 206.0 269.1 254.6 241.7 240.2 272.2 Net income 766.2 716.5 719.1 698.0 882.3 836.4 818.0 864.7 911.1 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 766.2 716.5 719.1 698.0 882.3 836.4 818.0 864.7 911.1 Net Income Attributable to Common Shareholders of CME Group 756.6 707.5 710.0 689.1 871.1 825.9 807.9 853.8 899.7 Effective Tax Rate 23.0% 23.3% 23.4% 22.8% 23.4% 23.3% 22.8% 21.7% 23.0% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.11 1.97 1.98 1.92 2.43 2.30 2.25 2.38 2.50 Diluted EPS 2.11 1.97 1.98 1.92 2.42 2.30 2.25 2.37 2.50 Weighted average number of common stock shares: Basic Shares 358,609 358,641 358,715 358,885 358,933 358,940 359,020 359,197 359,258 Diluted Shares 359,180 359,205 359,288 359,190 359,313 359,429 359,619 359,693 359,833 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --